Concepedia

Mark Chan

MC

Statistics

Publications

5

Citations

223

H-Index

5

Active since

2017

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mayo Clinic

Mayo Clinic in Arizona

WinnMed

Tisch Hospital

Mark Chan is an author at Icahn School of Medicine at Mount Sinai specializing in life sciences, tumor necrosis factor receptor 1 signaling, and tnfr1 signaling.

ORCID

Publications per year

2017–2021

5

Publications

5

Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death

Justin Taft, Michael Markson, Diana Legarda et al. · Cell · 2021 · 138 citations · Full text

, , +13

Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)

Xin Xu, Matko Kalac, Michael Markson et al. · Cell Death and Disease · 2020 · 29 citations · Full text

, , +17

T cell–derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death

Nicholas Chun, Rosalind L. Ang, Mark Chan et al. · JCI Insight · 2021 · 23 citations · Full text

, , +17

<sup>18</sup> F-positron-emitting/fluorescent labeled erythrocytes allow imaging of internal hemorrhage in a murine intracranial hemorrhage model

Ye Wang, Feifei An, Mark Chan et al. · Journal of Cerebral Blood Flow & Metabolism · 2017 · 17 citations · Full text

, , +15

Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death

Rosalind L. Ang, Mark Chan, Diana Legarda et al. · Proceedings of the National Academy of Sciences · 2021 · 16 citations · Full text

, , +12

1–5 of 5